Literature DB >> 8067768

Molecular characterization of the gene encoding high-level mupirocin resistance in Staphylococcus aureus J2870.

J E Hodgson1, S P Curnock, K G Dyke, R Morris, D R Sylvester, M S Gross.   

Abstract

The nucleotide sequence of the ileS gene conferring high-level resistance to mupirocin in Staphylococcus aureus J2870 has been determined. The gene sequence is substantially different from that of the native ileS gene of S. aureus, indicating that high-level resistance to mupirocin results from the acquisition of a novel ileS gene.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8067768      PMCID： PMC188182          DOI： 10.1128/AAC.38.5.1205

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  24 in total

1.  Evidence from cassette mutagenesis for a structure-function motif in a protein of unknown structure.

Authors:  N D Clarke; D C Lien; P Schimmel
Journal:  Science       Date:  1988-04-22       Impact factor: 47.728

2.  Mupirocin-resistant Staphylococcus aureus.

Authors: 
Journal:  Lancet       Date:  1987-08-15       Impact factor: 79.321

3.  Translational efficiency of the Escherichia coli adenylate cyclase gene: mutating the UUG initiation codon to GUG or AUG results in increased gene expression.

Authors:  P Reddy; A Peterkofsky; K McKenney
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

4.  Interaction of pseudomonic acid A with Escherichia coli B isoleucyl-tRNA synthetase.

Authors:  J Hughes; G Mellows
Journal:  Biochem J       Date:  1980-10-01       Impact factor: 3.857

5.  Inhibition of isoleucyl-transfer ribonucleic acid synthetase in Escherichia coli by pseudomonic acid.

Authors:  J Hughes; G Mellows
Journal:  Biochem J       Date:  1978-10-15       Impact factor: 3.857

6.  Bacillus subtilis requires a "stringent" Shine-Dalgarno region for gene expression.

Authors:  L Band; D J Henner
Journal:  DNA       Date:  1984

7.  In-vitro activity of mupirocin ('pseudomonic acid') against clinical isolates of Staphylococcus aureus.

Authors:  M W Casewell; R L Hill
Journal:  J Antimicrob Chemother       Date:  1985-05       Impact factor: 5.790

8.  Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use.

Authors:  R Sutherland; R J Boon; K E Griffin; P J Masters; B Slocombe; A R White
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

9.  MSW, a yeast gene coding for mitochondrial tryptophanyl-tRNA synthetase.

Authors:  A M Myers; A Tzagoloff
Journal:  J Biol Chem       Date:  1985-12-05       Impact factor: 5.157

10.  Specific sequence homology and three-dimensional structure of an aminoacyl transfer RNA synthetase.

Authors:  T Webster; H Tsai; M Kula; G A Mackie; P Schimmel
Journal:  Science       Date:  1984-12-14       Impact factor: 47.728
View more
  44 in total

1.  Characterization of the mupA gene in strains of methicillin-resistant Staphylococcus aureus with a low level of resistance to mupirocin.

Authors:  S Fujimura; A Watanabe; D Beighton
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

2.  Insights into physiological and genetic mupirocin susceptibility in bifidobacteria.

Authors:  Fausta Serafini; Francesca Bottacini; Alice Viappiani; Enrico Baruffini; Francesca Turroni; Elena Foroni; Tiziana Lodi; Douwe van Sinderen; Marco Ventura
Journal:  Appl Environ Microbiol       Date:  2011-03-18       Impact factor: 4.792

3.  Amplification of the gene for isoleucyl-tRNA synthetase facilitates adaptation to the fitness cost of mupirocin resistance in Salmonella enterica.

Authors:  Wilhelm Paulander; Dan I Andersson; Sophie Maisnier-Patin
Journal:  Genetics       Date:  2010-02-22       Impact factor: 4.562

4.  High-level mupirocin resistance within methicillin-resistant Staphylococcus aureus pandemic lineages.

Authors:  Eduardo Pérez-Roth; Celeste López-Aguilar; Julia Alcoba-Florez; Sebastián Méndez-Alvarez
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

5.  Transient loss of high-level mupirocin resistance in Staphylococcus aureus due to MupA polymorphism.

Authors:  Daniel G Driscoll; Casey L Young; Urs A Ochsner
Journal:  Antimicrob Agents Chemother       Date:  2007-04-16       Impact factor: 5.191

6.  Mupirocin resistance in Staphylococcus aureus causing recurrent skin and soft tissue infections in children.

Authors:  J Chase McNeil; Kristina G Hulten; Sheldon L Kaplan; Edward O Mason
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

7.  Complete nucleotide sequence and comparative analysis of pPR9, a 41.7-kilobase conjugative staphylococcal multiresistance plasmid conferring high-level mupirocin resistance.

Authors:  Eduardo Pérez-Roth; Stephen M Kwong; Julia Alcoba-Florez; Neville Firth; Sebastián Méndez-Alvarez
Journal:  Antimicrob Agents Chemother       Date:  2010-03-08       Impact factor: 5.191

8.  Characterization of mupirocin-resistant Staphylococcus aureus from different geographic areas.

Authors:  M A Ramsey; S F Bradley; C A Kauffman; T M Morton; J E Patterson; D R Reagan
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

Review 9.  Current and Emerging Topical Antibacterials and Antiseptics: Agents, Action, and Resistance Patterns.

Authors:  Deborah A Williamson; Glen P Carter; Benjamin P Howden
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

10.  Molecular characterization of high-level mupirocin resistance in Staphylococcus pseudintermedius.

Authors:  Krešimir Matanovic; Eduardo Pérez-Roth; Selma Pintarić; Branka Šeol Martinec
Journal:  J Clin Microbiol       Date:  2012-12-26       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.